Analog Devices Available For Sale Securities Debt Securities Current decreased by 12.3% to $1.00B in Q1 2026 compared to the prior quarter.
An increase suggests higher liquidity and a conservative cash management strategy, while a decrease may indicate cash deployment for operations or acquisitions.
This represents the portion of a company's investment portfolio consisting of debt securities that are expected to be so...
Common among large-cap pharmaceutical firms maintaining significant cash reserves for R&D and M&A activities.
current_assets_available_for_sale_securities_debt_securi_87ec82| Q3 '23 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $439.67M | $371.82M | $371.46M | $0.00 | $1.15B | $1.15B | $1.14B | $1.00B |
| QoQ Change | — | — | -15.4% | -0.1% | -100.0% | — | +0.4% | -0.9% | -12.3% |
| YoY Change | — | — | — | — | — | +161.1% | +210.1% | +207.7% | — |